Perrigo Company received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand over-the-counter equivalent of Advil Dual Action Tablets 250 mg/125 mg. The Company anticipates launching the product by Spring 2023.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PRGO: